Trending Now
Paypal Holdings Inc (NASDAQ:PYPL) short term trade alert
I really like the look of PayPal (NASDAQ:PYPL) here on the short-term charts. The stock made a strong move since October and...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Moderna (NASDAQ:MRNA) Enters Licensing And Research Collaborations Agreement With Vertex (NASDAQ:VRTX)...
Moderna Inc. (NASDAQ:MRNA) has entered a strategic licensing and research collaboration agreement with Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) for the research and development of mRNAs...
MAKE IT MODERN
LATEST REVIEWS
Stock Market Stocks Take Center Stage (TIGR, FDCT, CME)
It’s a strange thing, but it may well be the ascendant idea: the big thing happening in the stock market is… stocks.
MAKE IT MODERN
PERFORMANCE TRAINING
Heat Biologics Inc. (NASDAQ:HTBX) Regains Its Continued Listing on the NASDAQ Stock Market
Heat Biologics Inc. (NASDAQ:HTBX) has regained its listing on the Nasdaq Stock Market. This was confirmed through a letter from the Listing Qualifications Department...
U.S. Stocks Decline Amidst Global Economic Concerns; Major Banks Hit Hard
Shares dipped on Tuesday due to rising concerns about the global economy, especially China's economic stability, and a downturn in U.S. banking...
Curis, Inc. (NASDAQ:CRIS) Announces CI-8993 IND Approval By The Food And Drug Administration
Curis, Inc. (NASDAQ:CRIS) recently announced that it received the Food and Drug Administration’s (FDA) approval of an Investigational New Drug (IND) application that it...
US FDA Gives Nod For Kitov Pharma Lt (NASDAQ:KTOV) To Conduct Phase 1/2 Clinical...
US FDA has accepted the IND Investigational New Drug application and permitted Kitov Pharma Lt (NASDAQ:KTOV) to launch phase 1/2 clinical study of NT219...
NextCure Inc (NASDAQ:NXTC) Releases Interim Data From Its Phase 1/2 Monotherapy Study Of NC318
NextCure Inc (NASDAQ:NXTC) recently released interim findings from its phase 1/2 Monothapy clinical study evaluating NC318.
The company revealed that it has decided not to...
MAKE IT MODERN
